Dallas Pharmaceuticals
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- DOMCI prolonged-release capsule, hard 20 mg+10 mg
- PANTADAL D tablet 40 mg+10 mg
- PANTADAL tablet 40 mg
- J01 - Antibacterianos para uso sistémico
- CEFICACY dispersible tablet 100 mg
- CEFICACY dispersible tablet 200 mg
- CEFICACY powder for syrup 50 mg/5 ml
- DALCEFA powder for solution for injection 1 g
- DALCEFA powder for solution for injection 250 mg
- DALCEFA SB powder for solution for injection 500 mg+500 mg
- DALTRIX powder for solution for injection 1 g
- DALTRIX powder for solution for injection 250 mg
- DALTRIX powder for solution for injection 500 mg
- KEFUEL tablet 250 mg
- KEFUEL tablet 500 mg
- M01 - Antiinflamatorios y antirreumáticos
- KETOLAS solution for injection 30 mg/1 ml
- KETOLAS tablet 10 mg
- P01 - Antiprotozoarios
- E DALTHER solution for injection 100 mg/2 ml
- S01 - Oftalmológicos
- KETOLAS eye drops, solution 0.5%